Advertisement

Topics

FASENRA (benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma

19:02 EST 14 Nov 2017 | BioMedReports - Blog

WILMINGTON, Del., Nov. 14, 2017/PRNewswire/ --  AstraZeneca(NYSE: AZN) and its global biologics research and development arm, MedImmune, today announced that the

Read more...

Original Article: FASENRA (benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma

NEXT ARTICLE

More From BioPortfolio on "FASENRA (benralizumab) Receives US FDA Approval For Severe Eosinophilic Asthma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...